Source: International Congress 2017 – Cystic fibrosis: clinical issues
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Bortoluzzi (Casier, Italy). Inhaled hypertonic saline + hyaluronic acid (HSHA) and HS alone in patients with Cystic Fibrosis (CF): a 2 years retrospective analysis in Treviso’s CF Unit.. 1348

Member's Comments

No comment yet.

Related content which might interest you: Clinical surveys with nebulised hypertonic saline (HS) in CF children Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Effects of dornase alfa and hypertonic saline on gas mixing in lung periphery in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Inhaled mannitol in cystic fibrosis: clinical experience in Verona CF centre Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020 Ventilation inhomogeneity (VI) and spirometry in response to intravenous antibiotics (IVab) in cystic fibrosis (CF) Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 p.Leu206Trp mutation: Genotype-phenotype correlation in 23 paediatric / adults cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Lung Clearance Index (LCI) in children = 12 years old with Cystic Fibrosis (CF) taking ORKAMBI at University Hospital Limerick (UHL) Source: International Congress 2018 – Evolving approaches to differential diagnosis Year: 2018 Inhaled dry powder mannitol in cystic fibrosis (CF): Microbiology results from the 6 month double-blind CF301 study Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Nontuberculous mycobacteria (NTM) in Cystic fibrosis (CF) patients over the last decade: real-life data from Verona CF center Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021 Hypoglycemia: An unrecognized problem in cystic fibrosis (CF) patients unmasked by continues glucose monitorisation (CGM) Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Outcomes at 6 months following NIV in adults with cystic fibrosis (CF): experience of a large UK centre Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Lung Clearance Index (LCI) derived from N2-Multiple Breath Washout (MBW) depicts worsening in airways colonization in pediatric Cystic Fibrosis (CF) patients (pts) Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020 A review of 50 cystic fibrosis (CF) patients referred to a UK transplant centre Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001 RCT Abstract - The effect of inhaled hypertonic saline on lung structure in preschool children with cystic fibrosis Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Prospective follow up over 1 year with N2 multiple breath washout (MBW) in children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Microbiological yield of oropharyngeal swab compared to induced sputum in children with cystic fibrosis (CF) < 5 years of age Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Adherence with inhaled colistimethate sodium during a 6 month study in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013